News

Innovent Announces Completion Of First Participant Dosed In The Seventh Phase 3 Clinical Trial (GLORY-OSA) Of Mazdutide In China
SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company tha ...